Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HSD17B2 antisense RNA 1 (HSD17B2-AS1) is a long non-coding antisense RNA gene located opposite to HSD17B2 on the genome[8]. As a member of the antisense RNA family, it is not translated into protein but is believed to regulate the expression of HSD17B2, which encodes a key enzyme involved in the inactivation of steroid hormones[6][3]. Antisense RNA molecules such as HSD17B2-AS1 can influence their sense gene counterparts by modulating transcription, RNA processing, or chromatin structure, a common mechanism for lncRNAs[3]. However, there is currently no direct evidence that HSD17B2-AS1 serves as a receptor, enzyme, transporter, or other conventional drug target, nor are there any described drugs or therapeutic strategies directly targeting this RNA[2][8][6][3]. No specific roles in human disease have been firmly established for HSD17B2-AS1 itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HSD17B2 antisense RNA 1 (HSD17B2-AS1).